Miotic effect of brimonidine tartrate 0.15% ophthalmic solution in normal eyes

Journal of Cataract and Refractive Surgery

Volumn 30, Issue 8, 2004, Pages 1702-1706

  Thordsen, John E ^a   Bower, Kraig S ^a,b   Warren, Brent B ^a   Stutzman, Richard ^a  

^a Center for Refractive Surgery   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS ACTING ON THE EYE; BRIMONIDINE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; LUMINANCE; MALE; MIOSIS; NIGHT VISION; NORMAL HUMAN; PHOTOPIC VISION; PRIORITY JOURNAL; PUPIL; PUPILLOMETRY; UNITED STATES;

ADRENERGIC ALPHA-AGONISTS; ADULT; ANTIHYPERTENSIVE AGENTS; DARK ADAPTATION; FEMALE; HUMANS; INTRAOCULAR PRESSURE; LIGHT; MALE; OPHTHALMIC SOLUTIONS; PUPIL; QUINOXALINES;

EID: 4143108061     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrs.2003.12.037     Document Type: Article

References (22)

1. Martínez C.E., Applegate R.A., Klyce S.D., et al. Effect of pupillary dilation on corneal optical aberrations after photorefractive keratectomy. Arch Ophthalmol. 116:1998;1053-1062
2. Fan-Paul N.I., Li J., Miller J.S., Florakis G.J. Night vision disturbances after corneal refractive surgery. Surv Ophthalmol. 47:2002;533-546
3. Vernon W., Bullimore M., Maloney R.K. Visual performance after photorefractive keratectomy; a prospective study. Arch Ophthalmol. 114:1996;1465-1472
4. Endl M.J., Martinez C.E., Klyce S.D., et al. Effect of larger ablation zone and transition zone on corneal optical aberrations after photorefractive keratectomy. Arch Ophthalmol. 119:2001;1159-1164
5. Eggink F.A., Beekhuis W.H., Trokel S.L., den Boon J.M. Enlargement of the photorefractive keratectomy optical zone. J Cataract Refract Surg. 22:1996;1159-1164
6. Boxer Wachler B.S., Durrie D.S., Assil K.K., Krueger R.R. Role of clearance and treatment zones in contrast sensitivity. significance in refractive surgery J Cataract Refract Surg. 25:1999;16-23
7. Oliver K.M., Hemenger R.P., Corbett M.C., et al. Corneal optical aberrations induced by photorefractive keratectomy. J Cataract Refract Surg. 13:1997;246-254
8. LeBlanc R.P. Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension; the Brimonidine Study Group. Ophthalmology. 105:1998;1960-1967
9. Derick R.J., Robin A.L., Walters T.R., et al. Brimonidine tartrate; a one-month dose response study. Ophthalmology. 104:1997;131-136
10. McDonald J.E. II, El-Moatassem Kotb A.M., Decker B.B. Effect of brimonidine tartrate ophthalmic solution 0.2% on pupil size in normal eyes under different luminance conditions. J Cataract Refract Surg. 27:2001;560-564
11. Mundorf T., Williams R., Whitcup S., et al. A 3-month comparison of efficacy and safety of brimonidine-purite 0.15% and brimonidine 0.2% in patients with glaucoma or ocular hypertension. J Ocular Pharmacol Ther. 19:2003;37-44
12. Katz L.J. Twelve-month evaluation of brimonidine-purite versus brimonidine in patients with glaucoma or ocular hypertension. J Glaucoma. 11:2002;119-126
13. Colvard M. Preoperative measurement of scotopic pupil dilation using an office pupillometer. J Cataract Refract Surg. 24:1998;1594-1597
14. Solomon K.D., Holzer M.P., Sandoval H.P., et al. Refractive surgery survey 2001. J Cataract Refract Surg. 28:2002;346-355
15. Battat L., Macri A., Dursun D., Pflugfelder S.C. Effects of laser in situ keratomileusis on tear production, clearance, and the ocular surface. Ophthalmology. 108:2001;1230-1235
16. Hovanesian J.A., Shah S.S., Maloney R.K. Symptoms of dry eye and recurrent erosion syndrome after refractive surgery. J Cataract Refract Surg. 27:2001;577-584
17. Yan Z., Zhu S., Gu X., et al. Topographical evaluation of centration of excimer laser photorefractive keratectomy. Zhonghua Yan Ke Za Zhi. 33:1997;136-138. [Chinese]
18. Taylor N.M., Eikelboom R.H., van Sarloos P.P., Reid P.G. Determining the accuracy of an eye tracking system for laser refractive surgery. J Refract Surg. 16:2000;S643-S646
19. Tsai Y.-Y., Lin J.-M. Ablation centration after active eye-tracker-assisted photorefractive keratectomy and laser in situ keratomileusis. J Cataract Refract Surg. 26:2000;28-34
20. Jampel H.D., Robin A.L., Quigley H.A., Pollack I.P. Apraclonidine; a one-week dose-response study. Arch Ophthalmol. 106:1988;1069-1073
21. Stewart W.C., Laibovitz R., Horwitz B., et al. A 90-day study of the efficacy and side effects of 0.25% and 0.5% apraclonidine vs 0.5% timolol. Arch Ophthalmol. 114:1996;938-942
22. Robin A.L. Short-term effects of unilateral 1% apraclonidine therapy. Arch Ophthalmol. 106:1988;912-915